258 related articles for article (PubMed ID: 16077407)
21. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
22. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
Uy KL; Darling G; Xu W; Yi QL; De Perrot M; Pierre AF; Waddell TK; Johnston MR; Bezjak A; Shepherd FA; Keshavjee S
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
[TBL] [Abstract][Full Text] [Related]
23. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
24. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
25. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
26. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?
Chamogeorgakis T; Anagnostopoulos C; Kostopanagiotou G; Bhora F; Toumpoulis I; Georgiannakis E; Nabong A; Dosios T; Harrison L; Connery C
Thorac Cardiovasc Surg; 2008 Apr; 56(3):148-53. PubMed ID: 18365973
[TBL] [Abstract][Full Text] [Related]
27. Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer.
Fujita S; Katakami N; Takahashi Y; Hirokawa K; Ikeda A; Tabata C; Mio T; Mishima M
Eur J Cardiothorac Surg; 2006 Jun; 29(6):896-901. PubMed ID: 16675259
[TBL] [Abstract][Full Text] [Related]
28. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers.
Shaikh AY; Haraf DJ; Salama JK; Salgia R; Hoffman PC; Ferguson MK; Connell PP
Am J Clin Oncol; 2007 Jun; 30(3):258-63. PubMed ID: 17551302
[TBL] [Abstract][Full Text] [Related]
30. Remediastinoscopy in restaging of lung cancer after induction therapy.
Marra A; Hillejan L; Fechner S; Stamatis G
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):843-9. PubMed ID: 18374765
[TBL] [Abstract][Full Text] [Related]
31. Preoperative anaemia does not affect the early postoperative outcome in patients with lung cancer.
Anile M; Venuta F; Diso D; Vitolo D; Longo F; De Giacomo T; Francioni F; Liparulo V; Ricella C; Ruberto F; Coloni GF
Minerva Chir; 2007 Dec; 62(6):431-5. PubMed ID: 18091652
[TBL] [Abstract][Full Text] [Related]
32. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
34. Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt.
Meacci E; Cesario A; Cusumano G; Lococo F; D'Angelillo R; Dall'armi V; Margaritora S; Granone P
Eur J Cardiothorac Surg; 2011 Sep; 40(3):656-63. PubMed ID: 21402479
[TBL] [Abstract][Full Text] [Related]
35. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.
Fischer S; Darling G; Pierre AF; Sun A; Leighl N; Waddell TK; Keshavjee S; de Perrot M
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1129-34. PubMed ID: 18407511
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer and its operable brain metastasis: survival rate and staging problems.
Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
[TBL] [Abstract][Full Text] [Related]
37. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy.
De Waele M; Hendriks J; Lauwers P; Ortmanns P; Vanroelen W; Morel AM; Germonpré P; Van Schil P
Eur J Cardiothorac Surg; 2006 Feb; 29(2):240-3. PubMed ID: 16386916
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary resection after high-dose and low-dose chest irradiation.
Cerfolio RJ; Bryant AS; Spencer SA; Bartolucci AA
Ann Thorac Surg; 2005 Oct; 80(4):1224-30; discussion 1230. PubMed ID: 16181844
[TBL] [Abstract][Full Text] [Related]
39. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
40. Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
Park BB; Park JO; Kim H; Ahn YC; Choi YS; Kim K; Kim J; Shim YM; Ahn JS; Park K
Lung Cancer; 2006 Sep; 53(3):323-30. PubMed ID: 16844258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]